-
My Account
In App
My Account
BSE Live
Oct 24, 16:01Prev. Close
20.98
Open Price
21.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Balance Sheet of Bharat Immunologicals and Biologicals Corporation (in Rs. Cr.) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | |
| Total Share Capital | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | |
| Reserves and Surplus | 44.62 | 62.17 | -9.14 | -22.71 | -12.50 | |
| Total Reserves and Surplus | 44.62 | 62.17 | -9.14 | -22.71 | -12.50 | |
| Total Shareholders Funds | 87.80 | 105.35 | 34.04 | 20.47 | 30.68 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.48 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 6.42 | 6.11 | 5.85 | 5.65 | 5.33 | |
| Total Non-Current Liabilities | 6.42 | 6.11 | 5.85 | 5.65 | 5.81 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 70.22 | 77.89 | 27.29 | 3.04 | 32.22 | |
| Trade Payables | 0.48 | 0.87 | 14.79 | 43.53 | 44.18 | |
| Other Current Liabilities | 13.72 | 17.16 | 17.58 | 53.26 | 11.27 | |
| Short Term Provisions | 7.02 | 5.35 | 4.42 | 0.88 | 0.80 | |
| Total Current Liabilities | 91.44 | 101.26 | 64.09 | 100.71 | 88.48 | |
| Total Capital And Liabilities | 185.66 | 212.73 | 103.99 | 126.83 | 124.96 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 115.33 | 84.08 | 4.23 | 4.47 | 4.70 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 31.90 | 31.90 | 0.22 | 0.22 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 115.33 | 115.98 | 36.13 | 4.68 | 4.92 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 26.82 | 21.03 | 20.09 | 14.00 | 10.01 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 10.44 | 10.29 | 13.81 | 15.13 | 11.30 | |
| Total Non-Current Assets | 152.60 | 147.30 | 70.03 | 33.81 | 26.22 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 1.43 | 36.25 | 13.49 | 51.72 | 14.44 | |
| Trade Receivables | 13.88 | 1.13 | 0.01 | 17.61 | 72.97 | |
| Cash And Cash Equivalents | 8.74 | 13.01 | 10.54 | 12.10 | 7.93 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OtherCurrentAssets | 9.02 | 15.04 | 9.92 | 11.59 | 3.39 | |
| Total Current Assets | 33.06 | 65.43 | 33.95 | 93.02 | 98.74 | |
| Total Assets | 185.66 | 212.73 | 103.99 | 126.83 | 124.96 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.04 | 0.04 | 0.04 | 0.66 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 84.98 | 74.97 | 95.12 | 88.03 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
05.06.2023
Bharat Immuno Standalone March 2023 Net Sales at Rs 7.65 crore, down 65.29% Y-o-Y
25.08.2022
Bharat Immuno Standalone June 2022 Net Sales at Rs 10.48 crore, down 26.28% Y-o-Y
01.06.2022
Bharat Immuno Standalone March 2022 Net Sales at Rs 22.04 crore, up 41.07% Y-o-Y
09.02.2022
Bharat Immuno Standalone December 2021 Net Sales at Rs 17.43 crore, down 30.83% Y-o-Y
05.06.2023
Bharat Immuno Standalone March 2023 Net Sales at Rs 7.65 crore, down 65.29% Y-o-Y
25.08.2022
Bharat Immuno Standalone June 2022 Net Sales at Rs 10.48 crore, down 26.28% Y-o-Y
01.06.2022
Bharat Immuno Standalone March 2022 Net Sales at Rs 22.04 crore, up 41.07% Y-o-Y
09.02.2022
Bharat Immuno Standalone December 2021 Net Sales at Rs 17.43 crore, down 30.83% Y-o-Y
